Soaptronic’s Germstar Antiseptic Rubs Clean On Ingredients, Not On Claims
Executive Summary
Claims that Germstar antiseptic cleanser line treat swine flu, E-coli, salmonella and norovirus are not part of an OTC final monograph or TFM, FDA says in warning letter. The products contain active ingredients FDA deferred from OTC monographs for consumer and health care rubs to await additional data.
You may also be interested in...
FDA Warns Purell Marketer For Claims About Ebola, Resistant-Bacteria Protection
GOJO Industries’ online claims for Purell Healthcare Advanced hand sanitizers – including statements about warding off potentially deadly infections – identify its products as unapproved drugs, the FDA asserts in a 17 January warning letter.
FDA’s Final Rule On OTC Antiseptic Rubs Affects Just 3% Of Market; Alcohol Rulemaking Deferred
The majority of over-the-counter hand sanitizers and wipes on the US market rely on ethyl alcohol, one of three active ingredients for which final rulemaking has been deferred to allow industry to generate additional safety and effectiveness data. FDA's final rule, released April 11, completes a series of related actions pertaining to OTC antiseptic drug products.
FDA Litigates To Wash Off Sanitizer Ebola Claim, Warns On Colloidal Silver Benefits
A complaint filed in federal court in California seeks an order to block Innovative BioDefense from distributing Zylast antiseptic hand sanitizer products that, due to its claims, are unapproved new drugs under FDA regulations. A warning letter to Silver Armor states that drug claims render its Silver Ramon and Natural Health brand products, which contain colloidal silver, unapproved new drugs and that the is noncompliant with supplement GMP regulations.